This is a prospective, single-center, observational study designed to to quantify complications following non cardiac intermediate and high-risk surgery, and to identify digital biomarkers (collected pre, and post-operatively by a connected device) enabling early early identification of patients with post-operative complications. Patients will be invited to wear a smartdevice during the perioperative period, and will receive questionnaires about their their health status.
Eligibility
Sex
ALL
Min age
18 Years
Max age
—
Healthy volunteers
No
Patients will be recruited prospectively for a total of 50 patients.
Inclusion criteria are :
* Patients scheduled for elective non cardiac intermediate or high-risk surgery under general anesthesia
* 18 years of age or older
* Capacity to understand french language
Exclusion criteria will be :
\- Patient refusal and/or inability to understand and sign informed consent
Primary outcome measure(s)
Comprehensive Complication Index — J30 post-op The primary endpoint was the overall postoperative morbidity following non cardiac intermediate and high-risk surgery as defined by the CCI (Comprehensive Complication Index), which calculates a patient's overall morbidity following surgery based on the Clavien-Dindo classification of complications. The Comprehensive Complication Index (CCI) reflects the severity of this overall burden of complications for the patient on a scale ranging from 0 (no complications) to 100 (death).
Trial sites (1)
Facility
City
Region
Status
CHUV
Lausanne
Canton of Vaud
More Centre Hospitalier Universitaire Vaudois trials in Switzerland
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
We use cookies to analyse site traffic and improve your experience. With your consent, we may also use cookies for advertising. You can change your choice at any time.
